Product Details
Deferoxamine Mesylate For Injection
Deferoxamine Mesylate2 g/Vial
Powder for Solution for Injection
Single-Use 50-mL Vial
DIN/PIN/NPN
02247022
Manufacturer
Pfizer Canada Inc.
Formulary Listing Date
0000-00-00
Unit Price
Amount MOH Pays
Coverage Status
Exceptional Access Program Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
V03AC01
Interchangeable Products
NOLU Clinical Criteria
NOEAP Criteria
| Therapeutic Class | Reimbursement Criteria |
|---|---|
| Unclassified EAP Drugs | These drugs are not currently listed in the Exceptional Access Program Reimbursement Criteria for Frequently Requested Drugs – August 8, 2023 Edition Physicians may wish to contact the EAP directly by phone at 416-327-8109 or 1-866-811-9893 or by email at EAPFeedback.MOH@ontario.ca to see if an unlisted drug product and/or indication may be considered for EAP funding. |